Literature DB >> 15125469

Health-related quality of life in patients with inflammatory bowel disease five years after the initial diagnosis.

T Bernklev1, J Jahnsen, E Aadland, J Sauar, T Schulz, I Lygren, M Henriksen, N Stray, O Kjellevold, M Vatn, B Moum.   

Abstract

BACKGROUND: Health-related quality of life (HRQOL) has become an important tool in evaluating patient satisfaction in inflammatory bowel disease (IBD). So far, few prospective follow-up studies have been done to identify variables that influence HRQOL. We aimed to identify demographic and clinical variables that influence HRQOL 5 years after diagnosis in patients with ulcerative colitis (UC) or Crohn disease (CD) included in a prospective follow-up study from 1990 to 1994 (the IBSEN study).
METHODS: All patients completed the Inflammatory Bowel Disease Questionnaire (IBDQ), a disease-specific quality-of-life questionnaire translated into Norwegian and validated. We present data from 497 patients (328 UC patients and 169 CD patients, mean age 43.3 years, 48% female). The impact of age, gender, smoking, symptom severity, disease distribution, rheumatic symptoms and surgery on IBD patients' HRQOL was analysed.
RESULTS: Women had a reduction in IBDQ total score of 10 points compared to men, CD patients had a reduction of 7.5 compared to UC patients. The patients with moderate/severe symptoms had a 50 points lower score than the patients without symptoms. The patients with rheumatic symptoms had a 10 points lower total score than the patients without these symptoms. All differences were statistically significant. The multiple regression analysis showed that symptom severity, rheumatic symptoms and female gender were the strongest predictors of reduction in HRQOL for both diagnosis groups.
CONCLUSION: IBD symptoms, rheumatic symptoms and female gender have a significant influence on patients' HRQOL as measured by IBDQ. This was confirmed by the regression analysis.

Entities:  

Mesh:

Year:  2004        PMID: 15125469     DOI: 10.1080/00365520310008386

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  37 in total

1.  Quality of life in patients with inflammatory bowel disease: translation, validity, reliability and sensitivity to change of the Norwegian version of the short health scale (SHS).

Authors:  Lars-Petter Jelsness-Jørgensen; Tomm Bernklev; Bjørn Moum
Journal:  Qual Life Res       Date:  2011-12-07       Impact factor: 4.147

2.  Estimation of quality of life in Cypriot patients with inflammatory bowel disease.

Authors:  Maria Tsoukka; Eleni Jelastopulu; Giagkos Lavranos; George Charalambous
Journal:  World J Gastroenterol       Date:  2017-01-07       Impact factor: 5.742

Review 3.  Inflammatory bowel disease: a Canadian burden of illness review.

Authors:  Angela Rocchi; Eric I Benchimol; Charles N Bernstein; Alain Bitton; Brian Feagan; Remo Panaccione; Kevin W Glasgow; Aida Fernandes; Subrata Ghosh
Journal:  Can J Gastroenterol       Date:  2012-11       Impact factor: 3.522

4.  Ulcerative colitis: no rise in mortality in a European-wide population based cohort 10 years after diagnosis.

Authors:  O Höie; L J Schouten; F L Wolters; I C Solberg; L Riis; I A Mouzas; P Politi; S Odes; E Langholz; M Vatn; R W Stockbrügger; B Moum
Journal:  Gut       Date:  2006-10-06       Impact factor: 23.059

5.  Meta-analysis of early bowel resection versus initial medical therapy in patient's with ileocolonic Crohn's disease.

Authors:  Éanna J Ryan; Gabriel Orsi; Michael R Boland; Adeel Zafar Syed; Ben Creavin; Michael E Kelly; Kieran Sheahan; Paul C Neary; Dara O Kavanagh; Deirdre McNamara; Des C Winter; James M O'Riordan
Journal:  Int J Colorectal Dis       Date:  2020-01-09       Impact factor: 2.571

6.  The impact of ulcerative colitis on patients' lives compared to other chronic diseases: a patient survey.

Authors:  David T Rubin; Marla C Dubinsky; Remo Panaccione; Corey A Siegel; David G Binion; Sunanda V Kane; Joseph Hopper
Journal:  Dig Dis Sci       Date:  2009-09-04       Impact factor: 3.199

Review 7.  Hematopoietic cell transplantation for Crohn's disease; is it time?

Authors:  Y Leung; M Geddes; J Storek; R Panaccione; P L Beck
Journal:  World J Gastroenterol       Date:  2006-11-07       Impact factor: 5.742

8.  Activation and perceived expectancies: correlations with health outcomes among veterans with inflammatory bowel disease.

Authors:  Gregory W Munson; Kenneth A Wallston; Robert S Dittus; Theodore Speroff; Christianne L Roumie
Journal:  J Gen Intern Med       Date:  2009-05-15       Impact factor: 5.128

9.  Impact of demographic factors, medication and symptoms on disease-specific quality of life in inflammatory bowel disease.

Authors:  Johanna Haapamäki; Ulla Turunen; Risto P Roine; Martti A Färkkilä; Perttu E T Arkkila
Journal:  Qual Life Res       Date:  2009-07-23       Impact factor: 4.147

Review 10.  Association Between Inflammatory Bowel Disease and Vitamin D Deficiency: A Systematic Review and Meta-analysis.

Authors:  Rita Del Pinto; Davide Pietropaoli; Apoorva K Chandar; Claudio Ferri; Fabio Cominelli
Journal:  Inflamm Bowel Dis       Date:  2015-11       Impact factor: 5.325

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.